Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 166

1.

The efficacy of adjunctive N-acetylcysteine in major depressive disorder: a double-blind, randomized, placebo-controlled trial.

Berk M, Dean OM, Cotton SM, Jeavons S, Tanious M, Kohlmann K, Hewitt K, Moss K, Allwang C, Schapkaitz I, Robbins J, Cobb H, Ng F, Dodd S, Bush AI, Malhi GS.

J Clin Psychiatry. 2014 Jun;75(6):628-36. doi: 10.4088/JCP.13m08454.

PMID:
25004186
[PubMed - indexed for MEDLINE]
2.

Impact of inflammation on neurotransmitter changes in major depression: an insight into the action of antidepressants.

Leonard BE.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:261-7. doi: 10.1016/j.pnpbp.2013.10.018. Epub 2013 Nov 2. Review.

PMID:
24189118
[PubMed - indexed for MEDLINE]
3.
4.

BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.

Ninan PT, Shelton RC, Bao W, Guico-Pabia CJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:86-91. doi: 10.1016/j.pnpbp.2013.09.016. Epub 2013 Oct 2.

PMID:
24096053
[PubMed - indexed for MEDLINE]
5.

DNA methylation in interleukin-11 predicts clinical response to antidepressants in GENDEP.

Powell TR, Smith RG, Hackinger S, Schalkwyk LC, Uher R, McGuffin P, Mill J, Tansey KE.

Transl Psychiatry. 2013 Sep 3;3:e300. doi: 10.1038/tp.2013.73.

PMID:
24002086
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Biological phenotypes underpin the physio-somatic symptoms of somatization, depression, and chronic fatigue syndrome.

Anderson G, Berk M, Maes M.

Acta Psychiatr Scand. 2014 Feb;129(2):83-97. doi: 10.1111/acps.12182. Epub 2013 Aug 17. Review.

PMID:
23952563
[PubMed - indexed for MEDLINE]
7.

ATP-binding cassette sub-family F member 1 (ABCF1) is identified as a putative therapeutic target of escitalopram in the inflammatory cytokine pathway.

Powell TR, Tansey KE, Breen G, Farmer AE, Craig IW, Uher R, McGuffin P, D'Souza UM, Schalkwyk LC.

J Psychopharmacol. 2013 Jul;27(7):609-15. doi: 10.1177/0269881113490329. Epub 2013 May 29.

PMID:
23719290
[PubMed - indexed for MEDLINE]
8.

Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression.

Ranjbar E, Shams J, Sabetkasaei M, M-Shirazi M, Rashidkhani B, Mostafavi A, Bornak E, Nasrollahzadeh J.

Nutr Neurosci. 2014 Feb;17(2):65-71. doi: 10.1179/1476830513Y.0000000066. Epub 2013 Nov 26.

PMID:
23602205
[PubMed - indexed for MEDLINE]
9.

Tryptophan metabolism and immunogenetics in major depression: a role for interferon-γ gene.

Myint AM, Bondy B, Baghai TC, Eser D, Nothdurfter C, Schüle C, Zill P, Müller N, Rupprecht R, Schwarz MJ.

Brain Behav Immun. 2013 Jul;31:128-33. doi: 10.1016/j.bbi.2013.04.003. Epub 2013 Apr 15.

PMID:
23597432
[PubMed - indexed for MEDLINE]
10.

Serotonin and interleukin-6: the role of genetic polymorphisms in IFN-induced neuropsychiatric symptoms.

Udina M, Moreno-España J, Navinés R, Giménez D, Langohr K, Gratacòs M, Capuron L, de la Torre R, Solà R, Martín-Santos R.

Psychoneuroendocrinology. 2013 Sep;38(9):1803-13. doi: 10.1016/j.psyneuen.2013.03.007. Epub 2013 Apr 6.

PMID:
23571152
[PubMed - indexed for MEDLINE]
11.

Inflammation, serotonin and major depression.

Catena-Dell'Osso M, Rotella F, Dell'Osso A, Fagiolini A, Marazziti D.

Curr Drug Targets. 2013 May 1;14(5):571-7. Review.

PMID:
23531160
[PubMed - indexed for MEDLINE]
12.

Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration.

Ohgi Y, Futamura T, Kikuchi T, Hashimoto K.

Pharmacol Biochem Behav. 2013 Feb;103(4):853-9. doi: 10.1016/j.pbb.2012.12.003. Epub 2012 Dec 19.

PMID:
23262300
[PubMed - indexed for MEDLINE]
13.

Beyond the resistance: how novel neurobiological understandings of depression may lead to advanced treatment strategies.

Jain R, Jackson WC.

J Clin Psychiatry. 2012 Nov;73(11):e30. doi: 10.4088/JCP.12020wc3.

PMID:
23218168
[PubMed - indexed for MEDLINE]
14.

Evidence for sustained elevation of IL-6 in the CNS as a key contributor of depressive-like phenotypes.

Sukoff Rizzo SJ, Neal SJ, Hughes ZA, Beyna M, Rosenzweig-Lipson S, Moss SJ, Brandon NJ.

Transl Psychiatry. 2012 Dec 4;2:e199. doi: 10.1038/tp.2012.120.

PMID:
23212583
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Dysregulated relationship of inflammation and oxidative stress in major depression.

Rawdin BJ, Mellon SH, Dhabhar FS, Epel ES, Puterman E, Su Y, Burke HM, Reus VI, Rosser R, Hamilton SP, Nelson JC, Wolkowitz OM.

Brain Behav Immun. 2013 Jul;31:143-52. doi: 10.1016/j.bbi.2012.11.011. Epub 2012 Nov 29.

PMID:
23201587
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Melancholic and atypical major depression--connection between cytokines, psychopathology and treatment.

Dunjic-Kostic B, Ivkovic M, Radonjic NV, Petronijevic ND, Pantovic M, Damjanovic A, Poznanovic ST, Jovanovic A, Nikolic T, Jasovic-Gasic M.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Jun 3;43:1-6. doi: 10.1016/j.pnpbp.2012.11.009. Epub 2012 Nov 28.

PMID:
23200828
[PubMed - indexed for MEDLINE]
17.

Electroconvulsive therapy exerts mainly acute molecular changes in serum of major depressive disorder patients.

Stelzhammer V, Guest PC, Rothermundt M, Sondermann C, Michael N, Schwarz E, Rahmoune H, Bahn S.

Eur Neuropsychopharmacol. 2013 Oct;23(10):1199-207. doi: 10.1016/j.euroneuro.2012.10.012. Epub 2012 Nov 22.

PMID:
23183131
[PubMed - indexed for MEDLINE]
18.

Responder and nonresponder patients exhibit different peripheral transcriptional signatures during major depressive episode.

Belzeaux R, Bergon A, Jeanjean V, Loriod B, Formisano-Tréziny C, Verrier L, Loundou A, Baumstarck-Barrau K, Boyer L, Gall V, Gabert J, Nguyen C, Azorin JM, Naudin J, Ibrahim EC.

Transl Psychiatry. 2012 Nov 13;2:e185. doi: 10.1038/tp.2012.112.

PMID:
23149449
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Personalized medicine in major depressive disorder -- opportunities and pitfalls.

Miller DB, O'Callaghan JP.

Metabolism. 2013 Jan;62 Suppl 1:S34-9. doi: 10.1016/j.metabol.2012.08.021. Epub 2012 Sep 26. Review.

PMID:
23021040
[PubMed - indexed for MEDLINE]
20.

Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.

Fornaro M, Rocchi G, Escelsior A, Contini P, Martino M.

J Affect Disord. 2013 Mar 5;145(3):300-7. doi: 10.1016/j.jad.2012.08.007. Epub 2012 Sep 14.

PMID:
22981313
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk